Boditech Med Inc. (KOSDAQ:206640)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,370
+10 (0.07%)
Jul 18, 2025, 3:30 PM KST
-22.07%
Market Cap313.14B
Revenue (ttm)144.17B
Net Income (ttm)27.86B
Shares Out21.79M
EPS (ttm)1,272.37
PE Ratio11.29
Forward PE8.91
Dividend150.00 (1.04%)
Ex-Dividend DateMar 31, 2025
Volume59,590
Average Volume106,693
Open14,470
Previous Close14,360
Day's Range14,270 - 14,580
52-Week Range13,350 - 21,050
Beta0.29
RSI45.37
Earnings DateAug 11, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;... [Read more]

Sector Healthcare
Founded 1998
Employees 515
Stock Exchange KOSDAQ
Ticker Symbol 206640
Full Company Profile

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.

Financial Statements

News

There is no news available yet.